Tibes, Raoul <br/><br/>
JAK2 inhibitors in the treatment of myeloproliferative neoplasms.  [electronic resource] 

 -  Expert opinion on investigational drugs  Dec 2012 
 - 1755-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1517/13543784.2012.721352  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Bone Marrow Neoplasms--drug therapy<br/>Humans<br/>Janus Kinase 2--antagonists & inhibitors<br/>Mutation<br/>Protein Kinase Inhibitors--therapeutic use<br/>STAT Transcription Factors--antagonists & inhibitors<br/>Signal Transduction